TrialBlood2025
Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS.
Ola Landgren et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
TrialBlood2025
Ola Landgren et al.PubMed ↗Publisher ↗
No numbers read from the abstract.